"Henry Ford Cancer Institute - Brownstown is dedicated to the care and treatment of cancer patients, offering one location for comfort and convenience. Our services include a multidisciplinary cancer team, cancer tumor boards, advanced radiation technology and chemotherapy. We also offer support services, including yoga and meditation classes, nutritional services and cancer support groups."

During the past decade, Henry Ford Cancer Institute-Downriver conducted 97 clinical trials. In the 10-year time frame, 97 clinical trials started and 31 clinical trials were completed, i.e. on average, 32% percent of trials that started reached the finish line to date. In the past 5 years, 30 clinical trials started and 26 clinical trials were completed. i.e. 86.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Henry Ford Cancer Institute-Downriver" #1 sponsor was "National Cancer Institute (NCI)" with 57 trials, followed by "SWOG Cancer Research Network" with 19 trials sponsored, "NRG Oncology" with 16 trials sponsored, "Alliance for Clinical Trials in Oncology" with 10 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 10 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Henry Ford Cancer Institute-Downriver" #1 collaborator was "National Cancer Institute (NCI)" with 57 trials as a collaborator, "NRG Oncology" with 21 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Radiation Therapy Oncology Group" with 2 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Henry Ford Cancer Institute-Downriver" are "Invasive Breast Carcinoma" (6 trials), "Recurrent Ovarian Carcinoma" (6 trials), "Metastatic Malignant Neoplasm in the Brain" (5 trials), "Recurrent Breast Carcinoma" (5 trials) and "Recurrent Fallopian Tube Carcinoma" (5 trials). Many other conditions were trialed in "Henry Ford Cancer Institute-Downriver" in a lesser frequency.

Most popular intervention types in "Henry Ford Cancer Institute-Downriver" are "Drug" (91 trials), "Other" (67 trials), "Biological" (46 trials), "Radiation" (38 trials) and "Procedure" (37 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (35 trials), "Quality-of-Life Assessment" (34 trials), "Biospecimen Collection" (21 trials), "Cisplatin" (20 trials) and "Computed Tomography" (19 trials). Other intervention names were less common.

The vast majority of trials in "Henry Ford Cancer Institute-Downriver" are 96 trials for "All" genders, 13 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "Henry Ford Cancer Institute-Downriver". undefined are not yet recruiting, 33 are recruiting, 65 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Henry Ford Cancer Institute-Downriver, 3 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Henry Ford Cancer Institute-Downriver, 5 "Phase 1" clinical trials were conducted, 57 "Phase 2" clinical trials and 70 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".